Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Elanco Animal Health is a drug manufacturers-specialty & generic business based in the US. Elanco Animal Health shares (ELAN) are listed on the NYSE and all prices are listed in US Dollars. Elanco Animal Health employs 9,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $20.62 |
|---|---|
| 52-week range | $19.34 - $37.49 |
| 50-day moving average | $22.96 |
| 200-day moving average | $27.42 |
| Wall St. target price | $30.43 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.75 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.62 from 2022-07-01
| 1 week (2022-06-24) | 0.05% |
|---|---|
| 1 month (2022-06-03) | -14.76% |
| 3 months (2022-04-04) | -21.18% |
| 6 months (2022-01-04) | -27.42% |
| 1 year (2021-07-02) | -40.98% |
|---|---|
| 2 years (2020-07-02) | -2.78% |
| 3 years (2019-07-03) | 34.75 |
| 5 years (2017-06-30) | N/A |
Valuing Elanco Animal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elanco Animal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Elanco Animal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8448. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Elanco Animal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Elanco Animal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Elanco Animal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.7 billion |
|---|---|
| Operating margin TTM | 9.75% |
| Gross profit TTM | $2.7 billion |
| Return on assets TTM | 1.74% |
| Return on equity TTM | -4.65% |
| Profit margin | -7.65% |
| Book value | $16.06 |
| Market capitalisation | $9.8 billion |
TTM: trailing 12 months
We're not expecting Elanco Animal Health to pay a dividend over the next 12 months.
Over the last 12 months, Elanco Animal Health's shares have ranged in value from as little as $19.34 up to $37.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Elanco Animal Health's is 0.7444. This would suggest that Elanco Animal Health's shares are less volatile than average (for this exchange).
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. .
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.